首页> 美国卫生研究院文献>World Journal of Transplantation >Massive haemorrhage in liver transplantation: Consequences prediction and management
【2h】

Massive haemorrhage in liver transplantation: Consequences prediction and management

机译:肝移植中的大出血:后果预测和处理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

From its inception the success of liver transplantation has been associated with massive blood loss. Massive transfusion is classically defined as > 10 units of red blood cells within 24 h, but describing transfusion rates over a shorter period of time may reduce the potential for survival bias. Both massive haemorrhage and transfusion are associated with increased risk of mortality and morbidity (need for dialysis/surgical site infection) following liver transplantation although causality is difficult to prove due to the observational design of most trials. The blood loss associated with liver transplantation is multifactorial. Portal hypertension secondary to cirrhosis results in extensive collateral circulation, which can bleed during hepatectomy particular if portal pressures are increased. Avoiding volume loading and maintenance of a low central venous pressure together with the use of vasopressors have been shown to reduce blood loss and transfusion during liver transplantation, but may increase the risk of renal impairment post-operatively. Coagulation defects may be present pre-transplant, but haemostasis is often re-balanced due to a deficit in both pro- and anti-coagulation factors. Further derangement of haemostasis may develop in the anhepatic and neohepatic phases due to absent hepatic metabolic function, hyperfibrinolysis and platelet sequestration in the donor liver. Point-of-care tests of coagulation such as the viscoelastic tests rotation thromboelastometry/thromboelastometry allow and more accurate and rapid assessment of these derangements in coagulation and guide the use of factor replacement and antifibrinolytics. Transfusion protocols guided by these tests have been shown to reduce transfusion rates compared with conventional coagulation tests, but have not shown improvements in mortality or morbidity. Pre-operative factors associated with massive transfusion include previous surgery, re-do transplantation, the aetiology and severity of liver disease. Intra-operatively the use of piggy-back technique and avoiding veno-veno bypass has been shown to reduced blood loss.
机译:从一开始,肝移植的成功就与大量失血有关。大规模输血通常定义为24小时内> 10个单位的红细胞,但是描述较短时间内的输血速率可能会降低生存偏差的可能性。尽管由于大多数试验的观察性设计难以证实因果关系,但肝移植后大量出血和输血均会增加死亡率和发病率(需要透析/手术部位感染)的风险增加。与肝移植相关的失血是多因素的。继发于肝硬化的门静脉高压症会导致广泛的侧支循环,这可能在肝切除术期间流血,特别是如果门静脉压力升高。避免体积负荷和维持低中心静脉压以及使用血管加压药已被证明可减少肝移植期间的失血和输血,但可能增加术后肾功能不全的风险。移植前可能存在凝血缺陷,但由于促凝因子和抗凝因子均不足,止血作用通常会重新平衡。由于供肝中肝脏代谢功能的缺乏,高纤维蛋白溶解和血小板隔离,在肝和新肝期可能出现止血的进一步紊乱。凝血的即时检验,例如粘弹性测试,旋转血栓弹力测定法/血栓弹力测定法,可以更准确,更快速地评估这些凝血紊乱,并指导因素替代和抗纤溶蛋白的使用。这些测试指导的输血方案已证明与常规凝血测试相比可降低输血率,但未显示死亡率或发病率有改善。与大量输血相关的术前因素包括先前的手术,再次移植,肝病的病因和严重程度。术中使用背piggy式技术和避免静脉-静脉旁路已显示可减少失血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号